questionsmedicales.fr
Environnement et santé publique
Environnement
Mouvements de l'eau
Mouvements de l'eau : Questions médicales fréquentes
Termes MeSH sélectionnés :
Complement System Proteins
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mouvements de l'eau : Questions médicales les plus fréquentes",
"headline": "Mouvements de l'eau : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mouvements de l'eau : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mouvements de l'eau"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Environnement",
"url": "https://questionsmedicales.fr/mesh/D004777",
"about": {
"@type": "MedicalCondition",
"name": "Environnement",
"code": {
"@type": "MedicalCode",
"code": "D004777",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.230"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Mouvements de l'eau",
"alternateName": "Water Movements",
"code": {
"@type": "MedicalCode",
"code": "D014872",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ryan S Wagner",
"url": "https://questionsmedicales.fr/author/Ryan%20S%20Wagner",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, Bowling Green State University, Bowling Green, OH, United States."
}
},
{
"@type": "Person",
"name": "Katelyn M McKindles",
"url": "https://questionsmedicales.fr/author/Katelyn%20M%20McKindles",
"affiliation": {
"@type": "Organization",
"name": "Great Lakes Center for Fresh Waters and Human Health, Bowling Green State University, Bowling Green, OH, United States."
}
},
{
"@type": "Person",
"name": "George S Bullerjahn",
"url": "https://questionsmedicales.fr/author/George%20S%20Bullerjahn",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, Bowling Green State University, Bowling Green, OH, United States."
}
},
{
"@type": "Person",
"name": "Miguel A Gonzalez",
"url": "https://questionsmedicales.fr/author/Miguel%20A%20Gonzalez",
"affiliation": {
"@type": "Organization",
"name": "Universidad Rey Juan Carlos, ESCET, Mostoles, 28933 Madrid, Spain."
}
},
{
"@type": "Person",
"name": "Alberto Zaragoza",
"url": "https://questionsmedicales.fr/author/Alberto%20Zaragoza",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, The University of Utah, Salt Lake City, Utah 84112-0850, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.",
"datePublished": "2023-04-11",
"url": "https://questionsmedicales.fr/article/37065697",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.15125"
}
},
{
"@type": "ScholarlyArticle",
"name": "Relationship between the complement system and serum lipid profile in patients with rheumatoid arthritis.",
"datePublished": "2024-07-12",
"url": "https://questionsmedicales.fr/article/39072319",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1420292"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis.",
"datePublished": "2024-07-08",
"url": "https://questionsmedicales.fr/article/38978073",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13075-024-03360-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Contribution of Complement Protein C1q in COVID-19 and HIV Infection Comorbid with Preeclampsia: A Review.",
"datePublished": "2022-06-03",
"url": "https://questionsmedicales.fr/article/35661665",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000524976"
}
},
{
"@type": "ScholarlyArticle",
"name": "Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37286573",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-023-38383-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Environnement",
"item": "https://questionsmedicales.fr/mesh/D004777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mouvements de l'eau",
"item": "https://questionsmedicales.fr/mesh/D014872"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mouvements de l'eau - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mouvements de l'eau",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mouvements de l'eau",
"description": "Comment diagnostiquer une déshydratation ?\nQuels tests pour évaluer l'équilibre hydrique ?\nQuels signes indiquent une surcharge hydrique ?\nComment détecter un déséquilibre électrolytique ?\nQuels symptômes nécessitent un diagnostic urgent ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Complement+System+Proteins&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mouvements de l'eau",
"description": "Quels sont les symptômes de la déshydratation ?\nComment reconnaître une surcharge hydrique ?\nQuels signes indiquent un déséquilibre hydrique ?\nQuels symptômes sont liés à l'hyperhydratation ?\nQuels symptômes d'un choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Complement+System+Proteins&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mouvements de l'eau",
"description": "Comment prévenir la déshydratation ?\nQuelles mesures pour éviter la surcharge hydrique ?\nComment maintenir un bon équilibre hydrique ?\nQuelles précautions pour les athlètes ?\nComment prévenir les déséquilibres électrolytiques ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Complement+System+Proteins&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mouvements de l'eau",
"description": "Comment traiter la déshydratation légère ?\nQuel traitement pour la surcharge hydrique ?\nComment gérer un déséquilibre électrolytique ?\nQuel est le traitement de l'hyperhydratation ?\nComment traiter un choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Complement+System+Proteins&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mouvements de l'eau",
"description": "Quelles complications de la déshydratation sévère ?\nQuels risques d'une surcharge hydrique prolongée ?\nQuelles complications d'un déséquilibre électrolytique ?\nQuels dangers de l'hyperhydratation ?\nQuelles complications du choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Complement+System+Proteins&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mouvements de l'eau",
"description": "Quels facteurs augmentent le risque de déshydratation ?\nQui est à risque de surcharge hydrique ?\nQuels médicaments augmentent le risque d'un déséquilibre électrolytique ?\nQuels comportements augmentent le risque d'hyperhydratation ?\nQuels facteurs de risque pour le choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Complement+System+Proteins&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déshydratation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par l'évaluation des symptômes cliniques et des tests sanguins."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'équilibre hydrique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins, urinaires et des mesures de poids peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surcharge hydrique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent œdème, hypertension et dyspnée."
}
},
{
"@type": "Question",
"name": "Comment détecter un déséquilibre électrolytique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des analyses sanguines mesurant les niveaux de sodium et potassium."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un diagnostic urgent ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Confusion, convulsions ou perte de conscience doivent être évalués rapidement."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la déshydratation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Soif intense, sécheresse de la peau, fatigue et urine foncée."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une surcharge hydrique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes incluent gonflement des membres, essoufflement et prise de poids rapide."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un déséquilibre hydrique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, crampes musculaires et troubles de la concentration."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'hyperhydratation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nausées, maux de tête et confusion mentale peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'un choc hypovolémique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pulsations rapides, peau froide et confusion mentale sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Comment prévenir la déshydratation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Boire régulièrement de l'eau, surtout par temps chaud ou lors d'exercices."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter la surcharge hydrique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Limiter l'apport en liquides et surveiller les signes d'œdème."
}
},
{
"@type": "Question",
"name": "Comment maintenir un bon équilibre hydrique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consommer des aliments riches en eau et surveiller l'apport en électrolytes."
}
},
{
"@type": "Question",
"name": "Quelles précautions pour les athlètes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "S'hydrater avant, pendant et après l'exercice pour éviter la déshydratation."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déséquilibres électrolytiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Avoir une alimentation équilibrée et surveiller les niveaux lors de maladies."
}
},
{
"@type": "Question",
"name": "Comment traiter la déshydratation légère ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation orale avec des solutions électrolytiques est recommandée."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la surcharge hydrique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Restriction hydrique et diurétiques peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "Comment gérer un déséquilibre électrolytique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments ou des modifications alimentaires peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de l'hyperhydratation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Réduction de l'apport hydrique et administration de diurétiques."
}
},
{
"@type": "Question",
"name": "Comment traiter un choc hypovolémique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Administration rapide de fluides intraveineux et traitement de la cause sous-jacente."
}
},
{
"@type": "Question",
"name": "Quelles complications de la déshydratation sévère ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des lésions rénales, des convulsions et un choc hypovolémique."
}
},
{
"@type": "Question",
"name": "Quels risques d'une surcharge hydrique prolongée ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut causer un œdème pulmonaire et des troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Quelles complications d'un déséquilibre électrolytique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des arythmies cardiaques et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels dangers de l'hyperhydratation ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut provoquer un œdème cérébral et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Quelles complications du choc hypovolémique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner une défaillance multi-organique et un décès si non traité."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de déshydratation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Âge avancé, maladies chroniques et climat chaud sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Qui est à risque de surcharge hydrique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes avec insuffisance cardiaque ou rénale sont particulièrement à risque."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque d'un déséquilibre électrolytique ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les diurétiques et certains laxatifs peuvent provoquer des déséquilibres."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque d'hyperhydratation ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation excessive de liquides sans équilibre électrolytique peut être risquée."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le choc hypovolémique ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Traumatismes, hémorragies et déshydratation sévère augmentent le risque."
}
}
]
}
]
}
IgA nephropathy (IgAN) is one of the leading causes of end-stage renal disease (ESRD). Urine testing is a non-invasive way to track the biomarkers used for measuring renal injury. This study aimed to ...
In the discovery phase, we analysed 22 IgAN patients who were divided into three groups (IgAN 1-3) according to their estimated glomerular filtration rate (eGFR). Eight patients with primary membranou...
In the discovery phase, 747 proteins were identified in the urine of IgAN and pMN patients. There were different urine protein profiles in IgAN and pMN patients, and the bioinformatics analysis reveal...
There were abundant complement components in the urine of IgAN patients, indicating that the activation of AP and LP is involved in IgAN progression. Urinary complement proteins may be used as biomark...
The complement system has been linked to the etiopathogenesis of rheumatoid arthritis (RA). Patients with RA exhibit a dysregulated profile of lipid molecules, which has been attributed to the inflamm...
430 patients with RA were recruited. New-generation techniques were employed to conduct functional assays of the three pathways of the complement system. Serum levels of various complement components ...
After multivariable analysis, several noteworthy associations emerged between the complement system and lipid molecules. Notably, complement components most strongly linked to the lipid profile were C...
The correlation between the complement system and lipid molecule patterns is pronounced in patients with RA. This relationship is predominantly positive and primarily associated with upstream compleme...
Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular (CV) events and CV mortality. Subclinical carotid atherosclerosis is independently associated with rates of incident CV...
430 patients with RA were recruited. Functional assays of the three pathways of the complement system, utilizing new-generation techniques, were assessed. Additionally, serum levels of individual comp...
After multivariable adjustment, which included traditional CV risk factors and disease-related data, C3a and C5a exhibited significant positive correlations with carotid intima media thickness. Additi...
The complement system and subclinical carotid atherosclerosis are linked in patients with RA....
Dysregulation in component 1q (C1q) levels is associated with weak placental development in preeclampsia (PE). Human immunodeficiency virus infection (HIV-1) triggers the C1q complex, resulting in ops...
Venous thromboembolism (VTE) is a common, multi-causal disease with potentially serious short- and long-term complications. In clinical practice, there is a need for improved plasma biomarker-based to...
Transplant-associated thrombotic microangiopathy remains a lethal complication of haematopoietic stem cell transplant and not all patients respond to terminal complement inhibitors. Qi et al. show tha...
The purpose of this review is to discuss the role of the complement system in the pathogenesis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) as well as the employment of co...
AAV has traditionally been considered a pauci-immune disease until recent findings demonstrated the pathogenic role of the complement system. The complement alternative pathway is crucial in AAV, and ...
The increased circulating levels of some complement components - as well as the consumption of others - in patients with AAV suggested a systemic activation of the complement system. Low C3 levels cor...
The complement (C) system is implicated in the etiopathogenesis of rheumatoid arthritis (RA). However, there is a lack of studies characterizing all three C pathways in RA patients. This study aimed t...
Neuroinflammation is emerging as an important pathological process in frontotemporal dementia (FTD), but biomarkers are lacking. We aimed to determine the value of complement proteins, which are key c...
We measured the complement proteins C1q and C3b in CSF by ELISAs in 224 presymptomatic and symptomatic GRN, C9orf72 or MAPT mutation carriers and non-carriers participating in the Genetic Frontotempor...
CSF C1q and C3b, as well as plasma C2 and C3, were elevated in symptomatic mutation carriers compared to presymptomatic carriers and non-carriers. In genetic subgroup analyses, these differences remai...
Elevated levels of CSF C1q and C3b, as well as plasma C2 and C3, demonstrate the presence of complement activation in the symptomatic stage of genetic FTD. Intriguingly, correlations with several dise...
Chronic spontaneous urticaria (CSU) is a common skin disorder characterized by daily or almost daily recurring skin edema and flare with itch and pruritus anywhere on the body for more than 6 weeks. A...